Life style-related diseases of the digestive system: Colorectal cancer as a life style-related disease: From carcinogenesis to medical treatment

Journal of Pharmacological Sciences

Volumn 105, Issue 2, 2007, Pages 129-132

  Takahashi, Hirokazu ^a   Yoneda, Kyoko ^a   Tomimoto, Ayako ^a   Endo, Hiroki ^a   Fujisawa, Toshio ^a   Iida, Hiroshi ^a   Mawatari, Hironori ^a   Nozaki, Yuichi ^a   Ikeda, Tamon ^a   Akiyama, Tomoyuki ^a   Yoneda, Masato ^a   Inamori, Masahiko ^a   Abe, Yasunobu ^a   Saito, Satoru ^a   Nakajima, Atsushi ^a   Nakagama, Hitoshi ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Aberrant crypt foci (ACF); Chemoprevention; Colorectal cancer; Life style related disease; Peroxisome proliferator activated receptor gamma (PPAR )

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; GLUCOSE; INSULIN; K RAS PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE;

ABDOMINAL OBESITY; ABERRANT CRYPT FOCI; AGE DISTRIBUTION; BLOOD GLUCOSE MONITORING; BODY MASS; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; DIABETES MELLITUS; GENE MUTATION; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; INTESTINE CRYPT; INTRAABDOMINAL FAT; LIFESTYLE; NONHUMAN; OBESITY; RISK FACTOR; SHORT SURVEY; TREATMENT DURATION; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 36148977136     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FM0070022     Document Type: Short Survey

References (25)

1. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987;36:54-59.
2. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J. 1984;288:1401-1404.
3. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54:254-260.
4. Folsom AR, Kaye SA, Sellers TA, Hong CP, Cerhan JR, Potter JD, et al. Body fat distribution and 5-year risk of death in older women. JAMA. 1993;269:483-487.
5. Anderson WF, Umar A, Brawley OW. Colorectal carcinoma in black and white race. Cancer Metastasis Rev. 2003;22:67-82.
6. Rougier P, Mitry E. Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol. 2003;14:ii3-ii5.
7. Kinzler KW, Vogelstein B, Lessons from hereditary colorectal cancer. Cell. 1996;87:159-170.
8. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.
9. Limburg PJ, Anderson KE, Johnson TW, Jacobs DR, Lazovich D, Hong CP, et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2005;14:133-137.
10. Chang CK, Ulrich CM. Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients. Diabetologia. 2003;46:595-607.
11. Larsson SC, Giovannucci E, Wolk A. Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care. 2005;28:1805-1809.
12. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999;91:542-547.
13. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, et al. Increased blood glucose and insulin, body size, and indent colorectal cancer. J Natl Cancer Inst. 1999;91:1147-1154.
14. Giovannucci E, Aasherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995;122:327-334.
15. Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut. 2006;55:285-291.
16. Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control. 2003;14:75-84.
17. Giovannucci E. Diet, body weight, and colorectal cancer: a summary of the epidemiologic evidence. J Womens Health. 2003;12:173-182.
18. El-Serag HB. Obesity and disease of the oesophagus and colon. Gastroenterol Clin North Am. 2005;34:63-82.
19. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva: World Health Organization; 1999.
20. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987;37:147-151.
21. Pretlow TP, O'Riordan MA, Somich GA, Amini SB, Pretlow TG. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis. 1992;13:1509-1512.
22. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998;339:1277-1284.
23. Sutherland LA, Bird RP. The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon. Cancer Lett. 1994;76:101-107.
24. Roncucci L, Stamp D, Medline A, Cullen JB, Bruce WR. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol. 1991;22:287-294.
25. Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA, et al. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res. 1991;51:1564-1567.